Drug Trial Radar · NCT06890598
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
700
Planned (sponsor's estimate)
Start
Mar 27, 2025
Primary completion
May 2029
Study completion Feb 2032
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- Collaborators
- AstraZeneca
- First posted
- Mar 24, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to assess if olomorasib in combination with pembrolizumab is more effective than the pembrolizumab and placebo combination in part A in participants with resected KRAS G12C-mutant NSCLC and to assess if olomorasib in combination with durvalumab is more effective than the durvalumab and placebo combination in part B in participants with unresectable KRAS G12C-mutant non-small cell lung cancer. The study may last up to 3 years for each participant.
Conditions
- Carcinoma, Non-Small-Cell Lung
Interventions
OlomorasibDrug
Administered orally.
PembrolizumabDrug
Administered intravenously (IV).
DurvalumabDrug
Administered IV.
PlaceboDrug
Administered orally.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part A: Disease-Free Survival (DFS) by Investigator AssessmentTime frame: Randomization to disease recurrence or death from any cause (Estimated as approximately 4 years).
- Part B: Progression-Free Survival (PFS) by BICRTime frame: Randomization to disease progression or death from any cause (Estimated as approximately 3 years).
Locations
368 sites in 29 countries. Site status is shown where the registry gives one.
Clearview Cancer Institute
Huntsville, Alabama · Recruiting
Infirmary Cancer Care
Mobile, Alabama · Not yet recruiting
City of Hope, Phoenix
Phoenix, Arizona · Not yet recruiting
The University of Arizona Cancer Center - North Campus
Tucson, Arizona · Recruiting
Highlands Oncology Group
Springdale, Arkansas · Recruiting
City of Hope, Duarte
Duarte, California · Not yet recruiting
City of Hope Lennar
Irvine, California · Not yet recruiting
UCLA Hematology/Oncology - Santa Monica
Los Angeles, California · Recruiting
Profound Research LLC
Oceanside, California · Recruiting
University of California, Irvine (UCI) Health - UC Irvine Medical Center
Orange, California · Recruiting
Stanford Cancer Center
Palo Alto, California · Recruiting
Kaiser Permanente San Diego Mission Road
San Diego, California · Recruiting
BASS Cancer Center
Walnut Creek, California · Recruiting
Hartford Hospital (HH)
Hartford, Connecticut · Recruiting
Sibley Memorial Hospital
Washington D.C., District of Columbia · Recruiting
Boca Raton Regional Hospital
Boca Raton, Florida · Recruiting
Florida Cancer Specialists - South
Fort Myers, Florida · Recruiting
Miami Cancer Institute at Baptist Health, Inc.
Miami, Florida · Recruiting
Ocala Oncology Center PL DBA Florida Cancer Affiliates - Ocala
Ocala, Florida · Recruiting
Florida Cancer Specialists North
St. Petersburg, Florida · Recruiting
Comprehensive Hematology Oncology
St. Petersburg, Florida · Recruiting
Moffitt Cancer Center
Tampa, Florida · Recruiting
Florida Cancer Specialists East
West Palm Beach, Florida · Recruiting
University Cancer & Blood Center, LLC
Athens, Georgia · Recruiting
Winship Cancer Institute
Atlanta, Georgia · Recruiting
City of Hope National Medical Center, Atlanta Cancer Center
Newnan, Georgia · Not yet recruiting
City of Hope, Chicago
Chicago, Illinois · Not yet recruiting
Northwestern Memorial Hospital
Chicago, Illinois · Suspended
University of Illinois at Chicago
Chicago, Illinois · Recruiting
University of Chicago Medical Center
Chicago, Illinois · Recruiting
Captain James A. Lovell Federal Health Care Center
North Chicago, Illinois · Recruiting
OSF Saint Francis Medical Center
Peoria, Illinois · Not yet recruiting
Springfield Clinic Main Campus
Springfield, Illinois · Recruiting
Parkview Research Center at Parkview Regional Medical Center
Fort Wayne, Indiana · Recruiting
Franciscan Health
Indianapolis, Indiana · Recruiting
Baptist Health Lexington
Lexington, Kentucky · Recruiting
Baptist Health Hamburg
Lexington, Kentucky · Recruiting
Mary Bird Perkins Cancer Center
Baton Rouge, Louisiana · Recruiting
Ochsner Health Ochsner Cancer Center - Baton Rouge
Baton Rouge, Louisiana · Recruiting
Ochsner Clinic Foundation
New Orleans, Louisiana · Recruiting
Showing 40 of 368 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.